-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OyxSGgoNyiLF4D3mjOa5qZmTV/8qJbNKcyMZ3t67CovePgUjQrNtAhgzEyVUnstI er5QHUb9+v+IY701KU7H1g== 0000313143-10-000100.txt : 20101108 0000313143-10-000100.hdr.sgml : 20101108 20101108165455 ACCESSION NUMBER: 0000313143-10-000100 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101104 FILED AS OF DATE: 20101108 DATE AS OF CHANGE: 20101108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HAEMONETICS CORP CENTRAL INDEX KEY: 0000313143 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042882273 STATE OF INCORPORATION: MA FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 400 WOOD RD CITY: BRAINTREE STATE: MA ZIP: 02184 BUSINESS PHONE: 7818487100 MAIL ADDRESS: STREET 1: 400 WOOD ROAD CITY: BRAINTREE STATE: MA ZIP: 02184 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RUXIN MICHAEL I CENTRAL INDEX KEY: 0001249549 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14041 FILM NUMBER: 101173022 MAIL ADDRESS: STREET 1: HAEMONETICS CORPORATION INCORPORATED STREET 2: 400 WOOD ROAD CITY: BRAINTREE STATE: MA ZIP: 02184 4 1 edgardoc.xml PRIMARY DOCUMENT X0303 4 2010-11-04 0 0000313143 HAEMONETICS CORP HAE 0001249549 RUXIN MICHAEL I 400 WOOD ROAD BRAINTREE MA 02184 0 1 0 1 VP Global Software Strategies VP Global Software Strategies Common Stock 2010-11-04 4 P 0 215.0 46.3356 A 215.0 D Acquisition of shares of Common Stock pursuant to the Employee Stock Purchase Plan. Participant elected to purchase shares at least six months in advance of the effective date of the transaction. Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan. By: Susan M. Hanlon For: Michael Ruxin M.D. 2010-11-05 -----END PRIVACY-ENHANCED MESSAGE-----